Literature DB >> 2723040

Monoclonal antibodies against the main immunogenic region of the acetylcholine receptor. Mapping on the intact molecule.

A A Kordossi1, S J Tzartos.   

Abstract

About two-thirds of the antibodies to the nicotinic acetylcholine receptor (AChR) in myasthenic patients, and in rats immunized with intact AChR, bind to the main immunogenic region (MIR) on the alpha-subunit. We tested all available anti-MIR monoclonal antibodies (mAbs) by competition experiments for binding on the intact AChR from Torpedo electric organ and human muscle. Practically complete competition between all possible paired combinations of anti-MIR mAbs was found. As a consequence, the MIR must be a very concrete and small region. Furthermore, the location of the MIR relative to some other less immunogenic regions was also determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723040     DOI: 10.1016/0165-5728(89)90070-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.

Authors:  S J Tzartos; M Remoundos
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor.

Authors:  I Papadouli; S Potamianos; I Hadjidakis; E Bairaktari; V Tsikaris; C Sakarellos; M T Cung; M Marraud; S J Tzartos
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

4.  Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants.

Authors:  S J Tzartos; A Efthimiadis; E Morel; B Eymard; J F Bach
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.